Improved Real-World Outcomes of Patients with Acute Promyelocytic Leukemia Treated with First-Line Arsenic Trioxide in Specialized Centers in Portugal Through a 24/7 Phone-Based Referral: A Study from the Portuguese Acute Leukemia Group
AuthID
P-019-25R
P-019-25R